市場調查報告書

大麻二酚 (CBD)的全球市場分析:機會及預測

Global Cannabidiol (CBD) Market (2019 Edition): Analysis By Source (Hemp, Marijuana), Application (Pharmaceuticals, Cosmetics Industry, Others): Opportunities and Forecast (2017-2024)

出版商 Azoth Analytics 商品編碼 913185
出版日期 內容資訊 英文 134 Pages
訂單完成後即時交付
價格
大麻二酚 (CBD)的全球市場分析:機會及預測 Global Cannabidiol (CBD) Market (2019 Edition): Analysis By Source (Hemp, Marijuana), Application (Pharmaceuticals, Cosmetics Industry, Others): Opportunities and Forecast (2017-2024)
出版日期: 2019年09月30日內容資訊: 英文 134 Pages
簡介

本報告提供全球大麻二酚 (CBD) 市場相關調查分析,統計、資訊 (市場規模、佔有率、成長要素),再加上新興趨勢,主要促進因素,課題、機會,主要企業等相關的系統性資訊。

第1章 調查手法

第2章 摘要整理

第3章 策略性建議

第4章 大麻二酚 (CBD) :產品預測

第5章 大麻二酚 (CBD) 市場預測

第6章 全球大麻二酚 (CBD) 市場動態

  • 推動市場要素
  • 阻礙市場要素
  • 市場趨勢

第7章 波特的五力分析

第8章 SWOT分析

第9章 全球大麻二酚 (CBD) 市場:分析

第10章 全球大麻二酚 (CBD) 市場:各市場區隔分析

  • 各來源
  • 各用途

第11章 全球大麻二酚 (CBD) 市場:各地區分析

第12章 北美的大麻二酚 (CBD) 市場:分析

第13章 北美的大麻二酚 (CBD) 市場:各市場區隔分析

第14章 美國的大麻二酚 (CBD) 市場:各國分析

第15章 加拿大的大麻二酚 (CBD) 市場:各國分析

第16章 歐洲的大麻二酚 (CBD) 市場:分析

第17章 歐洲的大麻二酚 (CBD) 市場:各市場區隔分析

第18章 德國的大麻二酚 (CBD) 市場:各國分析

第19章 亞太地區的大麻二酚 (CBD) 市場:分析

第20章 亞太地區的大麻二酚 (CBD) 市場:各市場區隔分析

第21章 澳洲的大麻二酚 (CBD) 市場:各國分析

第22章 其他地區的大麻二酚 (CBD) 市場:分析

第23章 企業簡介

  • Mary's Medicinals
  • Medical Marijuana, INC.
  • Canopy Growth Corporation
  • Aphria Inc.
  • Folium Biosciences
目錄

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of global cannabidiol market. The report analyses the global cannabidiol Market by source (hemp, marijuana) and by application (Pharmaceuticals, cosmetics, others) for the Regions (North America, Europe, APAC, ROW) and By Country (U.S, Canada, Germany, Australia) for the historical period of 2017-2018 and the forecast period of 2019-2024.

According to the Azoth Analytics research, the global cannabidiol market was valued at USD 708.55 for the year 2018.

Over the recent years, cannabidiol market has been witnessing considerable growth on the back of rise in demand of cannabidiol, rapid legalization across countries globally, growing acceptance and awareness among consumers regarding therapeutic effect of cannabidiol etc.

In addition, increasing investment, escalating number of cannabidiol manufactures, introduction of CBD infused cosmetic product etc. is anticipated to provide higher momentum to the market growth in the forecast period. However, strict regulation regarding the legalization of cannabidiol and illegal market of cannabidiol has been hindering the market growth.

Scope of the Report

Global Cannabidiol Market (Actual Period: 2017-2018, Forecast Period: 2019-2024)

  • Cannabidiol Market- Size, Growth, Forecast
  • Analysis By Source: Hemp and Marijuana
  • Analysis By Application: Pharmaceuticals, Cosmetic, Others

Regional Markets- North America, Europe, APAC, ROW (Actual Period: 2017-2018, Forecast Period: 2019-2024)

  • Cannabidiol Market- Size, Growth, Forecast
  • Analysis By Source: Hemp and Marijuana
  • Analysis By Application: Pharmaceuticals, Cosmetic, Others

Country Analysis - U.S., Canada, Germany, Australia (Actual Period: 2017-2018, Forecast Period: 2019-2024)

  • Cannabidiol Market- Size, Growth, Forecast
  • Analysis By Source: Hemp and Marijuana
  • Analysis By Application: Pharmaceuticals, Cosmetic, Others

Other Report Highlights

  • Market Dynamics - Drivers and Restraints.
  • Market Trends
  • Porter Five Forces Analysis.
  • SWOT Analysis.
  • Company Analysis - Mary's Medicinals, Medical Marijuana Inc., Canopy growth corporation, Aphria Inc., Folium biosciences.

Customization of the Report

The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.

Table of Contents

1.Research Methodology

2.Executive Summary

3.Strategic Recommendations

4. Cannabidiol (CBD): Product Outlook

5. Global Cannabidiol Market Outlook

6. Global Cannabidiol Market Dynamics

  • 6.1 Global Cannabidiol Market Drivers
    • 6.1.1 Growing awareness and acceptance of cannabidiol among consumers.
    • 6.1.2 Escalating number of cannabidiol Manufacturers
    • 6.1.3 Improving disposable income and introduction of new products.
    • 6.1.4 Enormous health benefits and potency of cannabidiol.
  • 6.2 Global cannabidiol Market Restraints
    • 6.2.1 Strict regulations against usage of cannabidiol .
    • 6.2.2 Escalating recreational use of cannabidiol .
  • 6.3 Global cannabidiol Market Trends
    • 6.3.1 Government legalizing the production and consumption of Cannabis
    • 6.3.2 Emerging cannabidiol infused food and beverage products

7.Porter's Five Force Analysis: Global Cannabidiol Market

8.SWOT Analysis: Global Cannabidiol Market

9.Global cannabidiol Market: An Analysis

10.Global Cannabidiol Market - Segment Analysis

  • 10.1 By Source (2018,2024)
    • 10.1.1 Global cannabidiol Market, By Source (hemp): 2017-2024 (USD Million)
    • 10.1.2 Global cannabidiol Market, By Source (marijuana): 2017-2024 (USD Million)
  • 10.2 By Application (2018,2024)
    • 10.2.1 Global cannabidiol Market, By Pharmaceuticals: 2017-2024 (USD Million)
    • 10.2.2 Global cannabidiol Market, By Cosmetic : 2017-2024 (USD Million)
    • 10.2.3 Global cannabidiol Market, By Others : 2017-2024 (USD Million)

11. Global cannabidiol Market: Regional Analysis

  • 11.1 Global cannabidiol Market, By Regional Share, By Value (2018,2024)

12. North America cannabidiol Market: An Analysis

  • 12.1 North America cannabidiol Market, By Value 2017-2024

13. North America cannabidiol Market: Segmental Analysis

  • 13.1. North America medical cannabis Market, By Source , By Value 2017-2024 (USD Million)
  • 13.2 North America medical cannabis Market, By Application , By Value 2017-2024 (USD Million)

14. United States Cannabidiol Market: Country Analysis

  • 14.1 United States Cannabidiol Market, By Value
  • 14.2 United States cannabidiol Market, By Source 2017-2024
  • 14.3 United States cannabidiol Market, By Application 2017-2024

15. Canada Cannabidiol (CBD) Market: Country Analysis

  • 15.1 Canada Cannabidiol Market, By Value
  • 15.2 Canada Cannabidiol Market- By Source
  • 15.3 Canada Cannabidiol Market- By Application

16.Europe Cannabidiol Market: An Analysis

  • 16.1 Europe Cannabidiol Market, By Value 2017-2024

17. Europe cannabidiol Market: Segment Analysis

  • 17.1 Europe cannabidiol Market, By Source 2017-2024 (USD Million)
  • 17.2 Europe cannabidiol Market, By Application 2017-2024 (USD Million)

18. Germany Cannabidiol (CBD) Market: Country Analysis

  • 18.1 Germany cannabidiol Market, By Value 2017-2024
  • 18.2 Germany cannabidiol Market, By Source 2017-2024
  • 18.3 Germany cannabidiol Market, By Application 2017-2024

19. Asia-Pacific cannabidiol Market: An Analysis

  • 19.1 Asia-Pacific cannabidiol Market, By Value 2017-2024

20. Asia Pacific Cannabidiol Market: Segment Analysis

  • 20.1 Asia-Pacific cannabidiol Market, By Source 2017-2024 (USD Million)
  • 20.2 Asia-Pacific cannabidiol Market, By Application 2017-2024 (USD Million)

21. Australia Cannabidiol (CBD) Market: Country Analysis

  • 21.1 Australia Cannabidiol Market: By Value
  • 21.2 Australia Cannabidiol Market: By Source
  • 21.3 Australia Cannabidiol Market: By Application

22. Rest of the World Cannabidiol Market: An Analysis 2017-2024

  • 22.1 Rest of the World Cannabidiol Market, By Value 2017-2024 (USD Million)
  • 22.2 Rest of the World Cannabidiol Market, By Source 2017-2024 (USD Million)
  • 22.3 Rest of the World Cannabidiol Market, By Application, 2017-2024 (USD Million)

23.Company Profiles

  • 23.1 Mary's Medicinals
  • 23.2 Medical Marijuana, INC.
  • 23.3 Canopy Growth Corporation
  • 23.4 Aphria Inc.
  • 23.5 Folium Biosciences

List of Figures

  • Figure 1: Global Cannabidiol Market Size, By Value, 2017-2024 (USD Million)
  • Figure 2: Global Cases of Depressive Disorders, By Region, 2019 (In %)
  • Figure 3: Global Prevalence of Prostate Cancer, 2013-2017, (In Thousands)
  • Figure 4: Global Health Expenditure Per Capita, By Select Countries, 2017, (USD)
  • Figure 5: Global Prevalence of Different Types of Cancer, 2014-2018 (In Thousand)
  • Figure 6: Global Prevalence of Different Types of Cancer, 2014-2018 (In Thousand)
  • Figure 7: Global Prevalence of Prostate Cancer, 2013-2017, (In Thousands)
  • Figure 8: Global cannabidiol Market Size, By Source (Hemp), By Value, 2017-2024 (USD Million)
  • Figure 9: Global cannabidiol Market Size, By Source (Marijuana), By Value, 2017-2024 (USD Million)
  • Figure 10: Global cannabidiol Market Size, By Source (Pharmaceuticals Industry), By Value, 2017-2024 (USD Million)
  • Figure 11: Global cannabidiol Market Size, By Application (Cosmetics ), By Value, 2017-2024 (USD Million)
  • Figure 12: Global cannabidiol Market Size, By Source (Others ), By Value, 2017-2024 (USD Million)
  • Figure 13: North America Cannabidiol Market Size, By Value, 2017-2024 (USD Million)
  • Figure 14: North America Prevalence of Depressive Disorders, 2013-2017, (In Thousands)
  • Figure 15: North America Population aged 65 and above, 2013-2017 (% of Total)
  • Figure 16: North America Healthcare Expenditure, 2012-2015 (% of GDP)
  • Figure 17: North America Cannabidiol Market- By Source (USD Million), 2017-2024
  • Figure 18: North America Cannabidiol Market- By Application (USD Million), 2017-2024
  • Figure 19: United States Cannabidiol Market Size, By Value, 2017-2024 (USD Million)
  • Figure 20 US Medical Doctors Per 10000 Population, 2013-2016
  • Figure 21: US Current Health Expenditure, By financing Schemes, 2012 - 2016 (In Millions)
  • Figure 22: US Population Aged 65 and Older, 2013-2017 (In Millions)
  • Figure 23: USA Cannabidiol Market- By Source (USD Million), 2017-2024
  • Figure 24: USA Cannabidiol Market- By Application (USD Million), 2017-2024
  • Figure 25: Canada Cannabidiol Market Size, By Value, 2017-2024 (USD Million)
  • Figure 26: Canada Medical Doctors Per 10000 Population, 2013-2017
  • Figure 27: Canada Current Health Expenditure, By financing Schemes, 2012 - 2016 (In Millions)
  • Figure 28: Canada Population Aged 65 and Older, 2013-2017 (In Millions)
  • Figure 29: Canada cannabidiol market : By Source (USD Million), 2017-2024
  • Figure 30: Canada cannabidiol Market- By Application (USD Million), 2017-2024
  • Figure 31: Europe Cannabidiol Market Size, By Source 2017-2024 (USD Million)
  • Figure 32: Europe Prevalence of Depressive Disorders, 2013-2017, (In Thousands)
  • Figure 33: Europe Population aged 65 and above, 2013-2017 (% of Total)
  • Figure 34: Europe Healthcare Expenditure, 2012-2015 (% of GDP)
  • Figure 35: Europe Cannabidiol Market- By Source (USD Million), 2017-2024
  • Figure 36: Europe Cannabidiol Market- By Application (USD Million), 2017-2024
  • Figure 37: Germany Cannabidiol Market Size, By Source , 2017-2024 (USD Million)
  • Figure 38: Germany Cannabidiol Market- By Source (USD Million), 2017-2024
  • Figure 39: Germany Cannabidiol Market- By Application (USD Million), 2017-2024
  • Figure 40: Asia-Pacific Cannabidiol Market Size, By Payments, By Value, 2017-2024 (USD Million)
  • Figure 41: Asia - Pacific Cannabidiol Market- By Source (USD Million), 2017-2024
  • Figure 42: Asia- Pacific Cannabidiol Market- By Source (USD Million), 2017-2024
  • Figure 43: Australia Cannabidiol Market Size, By Value, 2017-2024 (In USD Million)
  • Figure 44: Australia Prevalence of Different Types of Neurological Disorders, 2016, 2017 (In Thousands)
  • Figure 45: Australia Medical Doctors Per 10000 Population, 2013-2016
  • Figure 46: Australia Current Health Expenditure, By financing Schemes, 2012 - 2016 (In Millions)
  • Figure 47: Australia Population Aged 65 and Older, 2013-2017 (In Millions)
  • Figure 48: Australia Cannabidiol Market- By Source (USD Millions), 2017-2024
  • Figure 49: Australia Cannabidiol Market- By Application (USD Millions), 2017-2024
  • Figure 50: Rest of the World Cannabidiol Market Size, By Value, 2017-2024 (USD Million)
  • Figure 51: Rest of the World Prevalence of Different Types of Neurological Disorders, 2016, 2017, (In Thousands)
  • Figure 52: Rest of the World Prevalence of Depressive Disorders, 2013-2017, (In Thousands)
  • Figure 53: Rest of the World Population aged 65 and above, 2013-2017 (% of Total)
  • Figure 54: Rest of the World Healthcare Expenditure, 2012-2015 (% of GDP)
  • Figure 55: Rest of the World Cannabidiol Market- By Source (USD Million), 2017-2024
  • Figure 56: Rest of the World Cannabidiol Market- By Application (USD Million), 2017-2024
  • Figure 57: Medical Marijuana Inc.'s Total Income (2016, 2017 , 2018) (In USD Million)
  • Figure 58: Medical Marijuana Inc.'s Gross Profit, (2016, 2017, 2018) (In USD Million)
  • Figure 59: Canopy Growth Corp's Revenue, 2015-2018 (USD Million)
  • Figure 60: Aphria Inc. Revenue, 2015-2018 (In USD Million)
  • Figure 61: Aphria Inc. Gross Profit, 2017, 2018 (In USD Million)
  • Figure 62: Aphria Inc. Net Income, 2017, 2018 (In USD Million)